Search Results 251-260 of 4971 for Wegovy
Mavacamten is used to treat symptomatic obstructive hypertrophic cardiomyopathy (HCM). This medicine helps improve your symptoms and ability to be active. This ...
To address this, Dr. Acosta and a team of Mayo Clinic researchers set out to study anti-obesity medications based on obesity phenotypes to enhance weight loss.
Examine patient's view on the perceived risk and benefits of opioid treatment; Examine patient's attitudes toward the provider who is prescribing opioids ...
Rochester, Minn. The purpose of this study is to create a registry of obese patients who have been phenotyped to understand the heterogeneity of obesity. Celiac ...
About this study. The purpose of this study is to test the effectiveness of semaglutide 2.4 mg SQ weekly in patients with obesity with a positive MyPhenome ...
About this study. The pupose of this study is to determine whether the scales marketed to the consumer are as accurate as the DEXA and InBody 970® for ...
The purpose of this study is to examine whether people without HFpEF display less visceral adipose tissue (VAT) compared to patients with diagnosed HFpEF.
Imperforate Anus, also known as anal atresia, is a rare birth defect. Unable to pass stool through the gastrointestinal tract, this condition can result in ...
The purpose of this study is to evaluate the use of occupancy sensors and control-logic to optimize energy savings in real-time based on the occupied condition ...
Givinostat is used to treat Duchenne muscular dystrophy (DMD). DMD is a rare, inherited muscle disease that is caused by the absence of a protein called ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.